Crossmark

ENDORSE: a prognostic model for endocrine therapy in estrogen‐receptor‐positive breast cancers

Published Online: 2022-06-07

Published Print: 2022-06-01

Authors

Nath, Aritro https://orcid.org/0000-0002-3225-4203
Cohen, Adam L

Bild, Andrea H https://orcid.org/0000-0003-4850-0453
Funding

Funding for this research was provided by:

HHS | NIH | National Cancer Institute (1U54CA209978)
License Information

Text and Data Mining valid from 2022-06-01

Version of Record valid from 2022-06-07
More Information

Article History

Received: 17 November 2021

Revised: 19 May 2022

Accepted: 20 May 2022

First Online: 7 June 2022

Document is current